• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
CommentaryHealth

COVID-19, flu, RSV: How wastewater monitoring can save lives as America faces the next ‘tripledemic’

By
Bill Hanage
Bill Hanage
Down Arrow Button Icon
By
Bill Hanage
Bill Hanage
Down Arrow Button Icon
October 16, 2023, 11:30 AM ET
Public health professionals are dreading a repeat of last year's surge in respiratory diseases.
Public health professionals are dreading a repeat of last year's surge in respiratory diseases.Ting Shen—Xinhua/Getty Images

Public health professionals are anxious about the coming fall and winter. Last year, the combination of COVID-19, respiratory syncytial virus (RSV), and influenza (the flu) overwhelmed America’s hospitals and emergency rooms, with the CDC stating the toll from flu alone between October 2022 to April 2023 may have caused upwards of 98,000 deaths. That’s a historically bad winter, even without the threat of COVID.

This year, another “tripledemic” seems inevitable–unless we proactively work to prevent and prepare for it. By monitoring the population for RSV and the flu before the season starts, we can respond fast when it is needed. The crucial tool we have to do this lies within each and every one of us—literally. Every time we flush, we are sending out into the world a sample that can provide a vital measure of the population’s health.

Wastewater-based epidemiology (WBE) is a reliable, nonintrusive, and relatively inexpensive way to track the spread of disease. By testing for the presence of dangerous pathogens or chemicals found in sewage, we can get a real-time picture of the health of a community. This trick has been used to track the spread of COVID-19, the poliovirus, monkeypox virus, and norovirus, as well as to measure high-risk substance use in communities, such as fentanyl, xylazine, and other opioids. The information has helped empower decision-makers to prepare for potential outbreaks and to act earlier–—whether that be prepping hospitals for a potential surge or implementing remote-work policies.

However, we are still in a place where many of these steps are implemented after public health crises are already underway. Not just shutting the stable door after the horse has bolted, but after the horse has bolted, met a nice other horse, had a bunch of little baby horses with them, and now they’re all back and eating our picnic. Last year, nearly 40% of U.S. households reported experiencing either COVID-19, the flu, or RSV in January—and RSV became the leading cause of lower-respiratory- tract-related hospitalization in children under one. Hospitals were filled and lives were lost.

As we saw with COVID-19, wastewater can be used to detect changes in RSV infections in the community before other monitoring systems can pick them up. By proactively testing our wastewater for RSV and the flu this season, we can be better prepared for a tripledemic—and let folks know what is going on in their communities. This approach can limit infection rates and hospitalizations, and, most importantly, save lives.

This cold and flu season, we’ll have an RSV vaccine available for people 60 years and older for the first time. Some may say that means we don’t need monitoring in place when there’s a preventative tool at our disposal, but that is simply untrue. In fact, WBE has an even more important role to play in our public health response as new vaccines are introduced. WBE can help to let us know where vaccines are most needed and even give insight on whether vaccines are effective against asymptomatic carriage of viruses like COVID-19.

We can get this tool into the hands of more public officials nationwide. The federal government can make funding available for cities and states to implement WBE programs and train staff. Several programs part of the Pandemic and All Hazards Preparedness Act (PAHPA) expired in September and the timeline for the reauthorization of this legislation is unclear. I hope to see the next iteration of PAHPA include WBE and empower agencies like ASPR and CDC to invest in wastewater surveillance as a pandemic preparedness and early warning tool.

By testing for viruses like influenza and RSV, we can significantly improve public health across our country and completely reimagine how our cities, hospitals, and families prepare for and deal with cold and flu season.

We also need to ensure that wastewater data is reliable, up-to-date, and comparable across regions, for instance, through the CDC’s National Wastewater Surveillance System (NWSS). It would allow public health officials to make informed decisions about how to respond to potential outbreaks.

For far too long, public health funding has existed in a cycle of panic and neglect: During a crisis, we invest heavily in needle-moving research and experimentation that bears great fruit, but the funding quickly dries up as urgency wanes. It is time we break this cycle. By investing in proactive wastewater monitoring, we can provide the nation and public health officials with a critical tool to prevent the next pandemic. Good data saves lives–and the time to act is now.

Bill Hanage is an associate professor at the Harvard T.H. Chan School of Public Health.

More must-read commentary published by Fortune:

  • Return-to-office mandates: Why tax breaks are not a reason for companies in states such as Texas, Utah, and New Jersey to force employees back
  • We analyzed 2 years of performance reviews for 13,000 workers. Here’s the proof that low-quality feedback is driving employee retention down
  • Burnout is attacking our brains and making it harder to excel at work. ‘Deliberate calm’ can help us adapt
  • The growing case for doing less: How harmless cancers are being overdiagnosed in America

The opinions expressed in Fortune.com commentary pieces are solely the views of their authors and do not necessarily reflect the opinions and beliefs of Fortune.

Join us at the Fortune Workplace Innovation Summit May 19–20, 2026, in Atlanta. The next era of workplace innovation is here—and the old playbook is being rewritten. At this exclusive, high-energy event, the world’s most innovative leaders will convene to explore how AI, humanity, and strategy converge to redefine, again, the future of work. Register now.
About the Author
By Bill Hanage
See full bioRight Arrow Button Icon

Latest in Commentary

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

Latest in Commentary

doctor
CommentaryMedicaid
Former White House advisor on the real reason your health care costs are going up: Medicare’s doctor pay gap
By Tomas J. PhilipsonJanuary 9, 2026
3 days ago
sudhakar
CommentaryM&A
I’m the SolarWinds CEO. Here’s why a $4.4 billion move to go private was right for us
By Sudhakar RamakrishnaJanuary 8, 2026
3 days ago
Jerome Adams
CommentaryVaccines
Trump’s former surgeon general: One year in, the war on vaccination is undoing the Trump administration’s health agenda
By Jerome AdamsJanuary 8, 2026
3 days ago
kappos
CommentaryEconomics
The Nobel Prize winners have a lesson for us all
By David J. KapposJanuary 8, 2026
4 days ago
Mark DesJardine
CommentaryM&A
Warner Bros. Discovery’s board isn’t choosing a deal — it’s avoiding one
By Mark DesJardineJanuary 8, 2026
4 days ago
A woman stands in front of a whiteboard speaking to a table of people.
Commentaryenterprise technology
AI isn’t failing your company. Your operating model is
By Katerin Le FolcalvezJanuary 8, 2026
4 days ago

Most Popular

placeholder alt text
Economy
Trump may be raising your taxes with his tariffs but he could actually cut inflation with them, too, SF Fed says
By Jake AngeloJanuary 6, 2026
5 days ago
placeholder alt text
AI
This CEO laid off nearly 80% of his staff because they refused to adopt AI fast enough. 2 years later, he says he'd do it again
By Nick LichtenbergJanuary 11, 2026
11 hours ago
placeholder alt text
Economy
As U.S. debt soars past $38 trillion, the flood of corporate bonds is a growing threat to the Treasury supply
By Jason MaJanuary 10, 2026
1 day ago
placeholder alt text
Economy
A Supreme Court ruling that strikes down Trump's tariffs would be the fastest way to revive the stalling job market, top economist says
By Jason MaJanuary 11, 2026
9 hours ago
placeholder alt text
Health
Bill Gates warns the world is going 'backwards' and gives 5-year deadline before we enter a new Dark Age
By Eleanor PringleJanuary 9, 2026
3 days ago
placeholder alt text
Success
Gen Z are arriving to college unable to even read a sentence—professors warn it could lead to a generation of anxious and lonely graduates
By Preston ForeJanuary 9, 2026
3 days ago

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.